Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-27 @ 9:22 PM
Study NCT ID:
NCT03762161
Status:
UNKNOWN
Last Update Posted:
2022-03-10
First Post:
2018-11-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer
Sponsor:
Rahul Parikh
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-30
First Submit QC Date:
None
Study First Post Date:
2018-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-09
Last Update Post Date:
2022-03-10
Last Update Post Date Type:
ACTUAL